Over the past 12 months, $INBX has been mentioned 5 times by 2 distinct FinTwit voices, with biotech-focused commentary dominating the discussion. @jacobplieth accounts for 4 mentions while @adamfeuerstein contributed 1 mention. The discussion began on July 25, 2025, and most recently occurred on May 8, 2026. The voices have focused on clinical trial developments and safety data related to the company's drug candidates.